SALT LAKE CITY—Biomerics, a vertically integrated contract manufacturer for the interventional medical device market, recently entered into definitive agreements to merge with Precision Concepts’ medical business (Precision Concepts Medical), the company said in a release.
The transaction includes the acquisition of the medical business of Precision Concepts International (PCI), as well as Precision Concepts Group (PCG), headquartered in Winston-Salem, North Carolina. Both Precision Concepts Medical businesses are headquartered in the United States, with operations in Harrisonburg, Virginia; Mebane, North Carolina; Winston-Salem, North Carolina; Haina, Dominican Republic; and Alajuela, Costa Rica, according to the release.
“We are excited to partner with the talented team at Precision Concepts Medical to deliver our shared vision,” said Biomerics CEO Travis Sessions, in a statement. “Precision Concepts Medical is a recognized leader that offers unique capabilities in micro-metals machining and stamping, injection micro-molding, and micro-assembly processes. The addition of these capabilities and manufacturing footprint extends Biomerics’ offerings as a leading supplier to the world’s largest medical device OEMs.”
The combined company will have more than 1.2 million square feet of manufacturing space across 13 locations, making Biomerics one of the “top 10 interventional contract development and manufacturing organizations (CDMOs) globally,” the company said.
Biomerics offers a new product development team of approximately 250 engineers, reportedly one of the largest in the industry. The company said it supplies 20 of the top 35 medical device OEMs in markets that include structural heart, electrophysiology, robotic surgery, cardiovascular disease, and endoscopy.